fbpx
Middle East Pharmacoeconomics and Drug Policy Summit 2024

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

OVERVIEW

As healthcare systems evolve, Pharmacoeconomics will remain a key discipline for guiding decisions that optimize outcomes, resource allocation, and the overall sustainability of healthcare.
The MEPDPS 2024: Middle East Pharmacoeconomics and Drug Policy Summit 2024 will take place on 23-24 February at JW Marriott Hotel Marina, Dubai, UAE and has been meticulously crafted to serve as a dynamic platform for thought leaders, policymakers, and key stakeholders to exchange insights, share experiences, in the areas focused on healthcare policy, the HEOR in healthcare decision making, economic evaluations, VBHC, the implications of HTA, responses to Real-World Evidence, collaboration, affordability, and equity in healthcare, that enhance patient outcomes, ensure accessibility to innovative therapies, and contribute to the sustainability of our healthcare infrastructure.

Who Attended 2023 Summit

who attended

Conference Key Facts

kwy facts

WHO SHOULD ATTEND

  • Regulatory authorities
  • Pharmacoeconomists
  • Health Economists
  • Health Technology Assessment Specialists
  • Payers
  • Healthcare providers
  • Pharma industry
  • Pharmacists and more

KEY BENEFITS OF ATTENDING

  • Highlight future opportunities and challenges in developing the healthcare and research economy in the GCC countries
  • Discuss the novel approaches to value assessment, achieving cost effective healthcare solutions and access to innovative medicines in the GCC
  • Understanding the principles of outcome based healthcare and evidence based medication
  • Reviewing pharmacoeconomics and outcomes research strategies
  • Exploring the real world data, the burden of disease and HTA to make proper assessments and support decision making

Summit chairman 

Ahmed Al Jedai
Ahmed Al Jedai
Founding President, Saudi Society of Clinical Pharmacy, Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, Ministry of Health, KSA

Scientific Committee Chair 

Hajer Al-Mudaiheem
Hajer Al-Mudaiheem

Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA

Strategic Partner

Scientific Committee Members

Ahmed Al Jedai
Ahmed Al Jedai

Founding President, Saudi Society of Clinical Pharmacy, Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, Ministry of Health, KSA

Ahmed Seyam
Ahmed Seyam

Director: Health Economics Health Systems Research – UHIA , Health Economics, Health Systems Healthcare Financing Consultant & MoHP, MoF, Cairo, Egypt

Anas Hamad
Anas Hamad

PhD, MSc, DMS, BPharm, RPh, Director of Pharmacy Department, National Center for Cancer Care & Research; Assistant Professor, College of Pharmacy, Qatar University, Qatar

Fabrizio Gianfrate
Fabrizio Gianfrate

Full Professor of Health Economics and Outcome Research, University of Ferrara and LUISS Business School Rome, Italy

Hajer Al-Mudaiheem
Hajer Al-Mudaiheem

Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA

Ibrahim Alrashdi
Ibrahim Alrashdi

Director General of Medical Supplies, Ministry of Health, Oman

Mohammed Alluhidan
Mohammed Alluhidan

Head of the Health Economics Unit, The Saudi Health Council, KSA

Mouna Jameleddine
Mouna Jameleddine

Director of HTA Department of INEAS (Tunisia); Former Vice-Chair of INAHTA (International Network of Agencies for HTA); Former Chair of the ISPOR HTA RoundTable for Middle East and Africa

Sara Al Dallal
Sara Al Dallal

MBBS, MSc, President, Emirates Health
Economics Society, Emirates Medical Association; Senior Health Service Specialist, Dubai Health Authority, UAE

Summit Packages

2-Days Summit Access

Physicians, Regulatory Authorities, Health Economists, Hospital and Community Pharmacists

Pharmaceutical Companies and Vendors

Early Bird Rate is valid until 15 February only

for Group Registration

Please contact: +971 4 361 9616

Thanks To Our Sponsors

Gold Sponsors

Amgen logo
astra-zeneca
Boston-Oncology
lilly logo
astra-zeneca

Silver Sponsors

Astella
Axios
Emmaus logo
astra-zeneca
hikma
Marcom
menarini logo
astra-zeneca

Bronze Sponsors

Lunatus logo
astra-zeneca

Media Partners

astra-zeneca
astra-zeneca
medgate
astra-zeneca
Medical Buyer
Medical Tourism
astra-zeneca